As the healthcare industry continues its transition toward value-based care, some medical ethicists have raised concerns about how education with an emphasis on value can potentially conflict with patients’ best interests. An opinion letter published in JAMA discusses various strategies for addressing these tensions.
As the healthcare industry continues its transition toward value-based care, some medical ethicists have raised concerns about how education with an emphasis on value can potentially conflict with patients’ best interests. An opinion letter published in JAMA discusses strategies for addressing these tensions.
The authors wrote that the calculation of value as a ratio of health outcomes to cost presents a number of pathways towards increased value. These methods include achieving better outcomes while marginally raising costs, reaching similar outcomes while reducing unnecessary expenses, or reducing health benefits to minimize spending, which results in a trade-off between quality and cost.
This last scenario is the one that has the potential to create “ethical tension between physicians’ commitment to providing cost-effective care while maintaining the primacy of patient welfare without compromise.” This balance is especially crucial in medical education, when trainees form a professional identity by combining their own personal beliefs with external influences.
High-value care education must instill in trainees a firm commitment to the importance of patient welfare during this formative stage, the authors wrote, instead of opening the door to more debatable cost-quality trade-offs. Teaching “should initially focus on circumstances in which the primacy of patient welfare is clearly fulfilled (ie, not in jeopardy of compromise) rather than circumstances in which there is ongoing controversy” on the definition of value.
Some examples of subjects to approach with caution in value-based care curricula include cost-effectiveness analysis, which has the potential to inadvertently condone withholding beneficial treatments in favor of saving costs. The authors also mention potentially harmful teaching practices like resident competitions to generate the least expensive evaluation, having students allocate budgets across patients, or using tools that track and display patient costs in real time. The emphasis on cost in these activities “could risk causing trainees to lose sight of individual patient welfare.”
Instead, the authors advocate for teaching the benefits of high-value care without compromising patient welfare by educating trainees on how to discuss costs with patients and avoid wasteful services. These approaches, which “tread lightly” in teaching cost-quality trade-offs, are particularly suitable for the earlier stages of medical education.
“Early on, it may be more appropriate to focus on teaching medical students to communicate about costs with patients. Later, more complex concepts of value could be introduced,” lead study author Matthew DeCamp, MD, PhD, said in a press release from Johns Hopkins Medicine. “This is much the same way we teach in other areas of medicine—blood draws first, heart catheterizations later.”
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More